课题基金 / 基金详情

Functional analysis of LR11 in vascular smooth muscle cells

Functional analysis of LR11 in vascular smooth muscle cells
LR11在血管平滑肌细胞中的功能分析
批准号:
12835002
负责人:
BUJO Hideaki
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

BUJO Hideaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
LR11, a member of the LDL receptor family, is highly expressed in vascular smooth muscle cells (SMCs) of the hyperplastic intima, but not media. To further clarify the involvement of LR11 in the process of atherosclerosis, we have characterized the migration and invasion activities, of LR11-overexpressing SMCs. LR11 cDNA was transfected into the rat SMC line, A7r5. Compared to mock cells (C-1), in the presence of PDGF-BB the transfected cells (R-1 and R-2) showed 3.5-4.0-fold higher expression of LR11 protein, 1.7-1.8-fold increased migration, and 2.0-2.2-fold elevated invasion activities, respectively. The increases were essentially abolished by the addition of receptor-associated protein (RAP), anti-LR11 antibodies, or Apo E. Immunological analyzes showed that urokinase-type plasminogen activator receptor (uPAR) levels were increased in LR11-overexpressing cells. Anti-uPA and anti-uPAR antibodies reduced the migration and invasion activities of R-1 and R-2 cells to baseline levels. RAP, anti-ER11 antibodies, and apo E decreased uPAR expression in the LR11-overexpressing cells by 〜50%. Cellular catabolism of uPAR was significantly decreased in R-1 and R-2 cells compared to control. Cultured SMCs isolated from intimae of atherosclerotic rabbit aortas showed increased expression levels of LR11 and uPAR, and enhanced migration and invasion compared to SMCs from medial layers. Overexpression of LR11 induces enhanced migration and invasion activities of intimal SMCs in vitro, likely via its regulation of the uPA/uPAR system.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Miyazaki O, Kobayashi J, Fukamachi I, Miida T, Bujo H, Saito Y.: "A new sandwich enzyme immunoassay for measurement of plasma pre-betal-HDL level"J Lipid Res.. 41(12). 2083-2088 (2000)
Miyazaki O、Kobayashi J、Fukamachi I、Miida T、Bujo H、Saito Y.:“一种用于测量血浆前 β-HDL 水平的新型夹心酶免疫测定法”J Lipid Res.. 41(12)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanaki T, Morisaki N, Bujo H, Takahashi K, Ishii I, Saito Y: "The regulatory expression of procollagen COOH-terminal proteinase enhancer in the proliferation of vascular smooth muscle cells."Biochem Biophys Res Commun. 270(3). 1049-54 (2000)
Kanaki T、Morisaki N、Bujo H、Takahashi K、Ishii I、Saito Y:“前胶原 COOH 末端蛋白酶增强剂在血管平滑肌细胞增殖中的调节表达。”Biochem Biophys Res Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirayama S, Bujo H, Yamazaki H, Kanaki T, Takahashi K, Saito Y.: "Differential expression of LR11 during proliferation and differentiation of cultured ~neuroblastoma cells"Biochem Biophys Res Commun. 275(2). 365-562 (2000)
Hirayama S、Bujo H、Yamazaki H、Kanaki T、Takahashi K、Saito Y.:“培养的神经母细胞瘤细胞增殖和分化过程中 LR11 的差异表达”Biochem Biophys Res Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Zhu Y., et al.: "Enhanced expression of LDLR family member LR11 increases migration of smooth muscle cells in vitro"Circulation. In press. (2002)
Zhu Y.等人:“LDLR家族成员LR11的表达增强可增加平滑肌细胞的体外迁移”循环。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Examinational significance and production mechanism of a circulating soluble receptor for the diagnosis of activated adipocytes to prevent diabetes
    • 批准号:
      16H05231
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2016
    • 负责人:
      BUJO Hideaki
    • 依托单位:
    Identification of the pathologically-transited immature cells diagnosed by soluble LR11
    • 批准号:
      15K15198
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2015
    • 负责人:
      BUJO Hideaki
    • 依托单位:
    Molecular clarification of trans-differentiation to brown adipocytes through the action of soluble receptor LR11
    Regulation of cellular cytoskeleton by the soluble LDL receptor family with the application for novel anti-atherosclerosis therapy
    • 批准号:
      21390277
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2009
    • 负责人:
      BUJO Hideaki
    • 依托单位:
    国内基金
    海外基金
    Hp感染和LR11在糖尿病大血管病变发生发展过程中的作用
    • 批准号:
      81760148
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32.0万元
    • 批准年份:
      2017
    • 负责人:
      金文龙
    • 依托单位:
    LR11和SorCS1在糖尿病慢性并发症发生发展过程中的作用
    • 批准号:
      81360134
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      49.0万元
    • 批准年份:
      2013
    • 负责人:
      金文龙
    • 依托单位: